Anatara Lifesciences Ltd (AU:ANR) has released an update.
Anatara Lifesciences Ltd reported a 28% decrease in net loss to $1,451,242 for the year ended 30 June 2024, marking an improvement over the previous period. The company’s net tangible asset backing per security also slightly decreased from 0.77 to 0.71 cents. No dividends were paid or declared during the year, and the financial statements have received an unqualified audit opinion with an emphasis on going concern.
For further insights into AU:ANR stock, check out TipRanks’ Stock Analysis page.
